Knockdown of connexin 43 attenuates balloon injury-induced vascular restenosis through the inhibition of the proliferation and migration of vascular smooth muscle cells

Han,Xiao-Jian; He,Dan; Xu,Liang-Jing; Chen,Min; Wang,Yi-Qi; Feng,Jiu-Geng; Wei,Min-Jun; Hong,Tao; Jiang,Li-Ping

doi:10.3892/ijmm.2015.2346

Knockdown of connexin 43 attenuates balloon injury-induced vascular restenosis through the inhibition of the proliferation and migration of vascular smooth muscle cells

Authors:
- Xiao-Jian Han
- Dan He
- Liang-Jing Xu
- Min Chen
- Yi-Qi Wang
- Jiu-Geng Feng
- Min-Jun Wei
- Tao Hong
- Li-Ping Jiang
View Affiliations

Affiliations: Department of Pharmacology, School of Pharmaceutical Science, Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China, Department of Neurosurgery, The First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: September 15, 2015 https://doi.org/10.3892/ijmm.2015.2346
Pages: 1361-1368

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Coronary artery disease (CAD) or atherosclerotic heart disease is one of the most common types of cardiovascular disease. Although percutaneous coronary intervention [PCI or percutaneous transluminal coronary angioplasty (PTCA)] is a mature, well-established technique used to treat atherosclerotic heart disease, its long‑term therapeutic effects are compromised by a high incidence of vascular restenosis (RS) following angioplasty. In our previous study, we found that the principal gap junction protein, connexin 43 (Cx43), in vascular smooth muscle cells (VSMCs) was involved in the development of vascular RS following angioplasty-induced balloon injury. However, the exact role action of Cx43 in vascular RS remains unclear. In the present study, we aimed to further examine whether the knockdown of Cx43 attenuates the development of vascular RS through the inhibition of the proliferation and migration of VSMCs. We found that the use of a lentiviral vector expressing shRNA targeting Cx43 (Cx43‑RNAi-LV) efficiently silenced the mRNA and protein expression of Cx43 in cultured VSMCs. In addition, MTT and Transwell assays were used to examined the proliferation and migration of the VSMCs, respectively. The results revealed that the knockdown of Cx43 by Cx43-RNAi-LV at a multiplicity of infection (MOI) of 100 significantly inhibited the proliferation and migration of the VSMCs in vitro. Notably, the knockdown of Cx43 also effectively attenuated the development of vascular RS and intimal hyperplasia following balloon injury in vivo. Taken together, our data suggest that Cx43 is involved in the development of vascular RS and intimal hyperplasia through the regulation of the proliferation and migration of VSMCs. Thus, the present study provides new insight into the pathogenesis of vascular RS, and suggests that further comfirms that Cx43 may well be a novel potential pharmacological target for preventing vascular RS following PCI.

View Figures

View References

1	Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK and Kent DM: Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 373:911–918. 2009. View Article : Google Scholar : PubMed/NCBI
2	Meads C, Cummins C, Jolly K, Stevens A, Burls A and Hyde C: Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Health Technol Assess. 4:1–153. 2000.PubMed/NCBI
3	Odell A, Grip L and Hallberg LR: Restenosis after percutaneous coronary intervention (PCI): experiences from the patients' perspective. Eur J Cardiovasc Nurs. 5:150–157. 2006. View Article : Google Scholar
4	Zhang C, Chaturvedi D, Jaggar L, Magnuson D, Lee JM and Patel TB: Regulation of vascular smooth muscle cell proliferation and migration by human sprouty 2. Arterioscler Thromb Vasc Biol. 25:533–538. 2005. View Article : Google Scholar : PubMed/NCBI
5	Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:487–517. 1995.PubMed/NCBI
6	Crowley ST, Ray CJ, Nawaz D, Majack RA and Horwitz LD: Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol. 269:H1641–H1647. 1995.PubMed/NCBI
7	Li F, Zhang C, Schaefer S, Estes A and Malik KU: ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery. Am J Physiol Heart Circ Physiol. 289:H2592–H2601. 2005. View Article : Google Scholar : PubMed/NCBI
8	Jia G, Cheng G, Gangahar DM and Agrawal DK: Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J Mol Cell Cardiol. 44:882–890. 2008. View Article : Google Scholar : PubMed/NCBI
9	Hervé JC, Phelan P, Bruzzone R and White TW: Connexins, innexins and pannexins: bridging the communication gap. Biochim Biophys Acta. 1719:3–5. 2005. View Article : Google Scholar : PubMed/NCBI
10	Bruzzone R, White TW and Paul DL: Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem. 238:1–27. 1996. View Article : Google Scholar : PubMed/NCBI
11	Elfgang C, Eckert R, Lichtenberg-Fraté H, Butterweck A, Traub O, Klein RA, Hülser DF and Willecke K: Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol. 129:805–817. 1995. View Article : Google Scholar : PubMed/NCBI
12	van Kempen MJ and Jongsma HJ: Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol. 112:479–486. 1999. View Article : Google Scholar
13	Hong T and Hill CE: Restricted expression of the gap junctional protein connexin 43 in the arterial system of the rat. J Anat. 192:583–593. 1998. View Article : Google Scholar : PubMed/NCBI
14	Li X and Simard JM: Increase in Cx45 gap junction channels in cerebral smooth muscle cells from SHR. Hypertension. 40:940–946. 2002. View Article : Google Scholar : PubMed/NCBI
15	Matsushita T, Rama A, Charolidi N, Dupont E and Severs NJ: Relationship of connexin43 expression to phenotypic modulation in cultured human aortic smooth muscle cells. Eur J Cell Biol. 86:617–628. 2007. View Article : Google Scholar : PubMed/NCBI
16	Ram R, Wescott AP, Varandas K, Dirksen RT and Blaxall BC: Mena associates with Rac1 and modulates connexin 43 remodeling in cardiomyocytes. Am J Physiol Heart Circ Physiol. 306:H154–H159. 2014. View Article : Google Scholar :
17	Kieken F, Mutsaers N, Dolmatova E, Virgil K, Wit AL, Kellezi A, Hirst-Jensen BJ, Duffy HS and Sorgen PL: Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ Res. 104:1103–1112. 2009. View Article : Google Scholar : PubMed/NCBI
18	Qu J, Volpicelli FM, Garcia LI, Sandeep N, Zhang J, Márquez-Rosado L, Lampe PD and Fishman GI: Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart. Circ Res. 104:365–371. 2009. View Article : Google Scholar :
19	Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R, Delcayre C, Renaud JF, Dunia I, Segretain D and Hatem SN: Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res. 72:69–79. 2006. View Article : Google Scholar : PubMed/NCBI
20	Han XJ, Chen M, Hong T, Zhu LY, He D, Feng JG and Jiang LP: Lentivivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury. Int J Mol Med. 35:885–892. 2015.PubMed/NCBI
21	Zhang J, Guo C, Wang R, Huang L, Liang W, Liu R and Sun B: An Egr-1-specific DNAzyme regulates Egr-1 and proliferating cell nuclear antigen expression in rat vascular smooth muscle cells. Exp Ther Med. 5:1371–1374. 2013.PubMed/NCBI
22	Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y and Feng Y: Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer. 107:746–756. 2006. View Article : Google Scholar : PubMed/NCBI
23	Barac YD, Zeevi-Levin N, Yaniv G, Reiter I, Milman F, Shilkrut M, Coleman R, Abassi Z and Binah O: The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc Res. 68:75–86. 2005. View Article : Google Scholar : PubMed/NCBI
24	Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R and Halliday D: Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech. 52:301–322. 2001. View Article : Google Scholar : PubMed/NCBI
25	Meng QH, Yang G, Yang W, Jiang B, Wu L and Wang R: Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol. 170:1406–1414. 2007. View Article : Google Scholar : PubMed/NCBI
26	Brisset AC, Isakson BE and Kwak BR: Connexins in vascular physiology and pathology. Antioxid Redox Signal. 11:267–282. 2009. View Article : Google Scholar
27	Déglise S, Martin D, Probst H, Saucy F, Hayoz D, Waeber G, Nicod P, Ris HB, Corpataux JM and Haefliger JA: Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia. J Vasc Surg. 41:1043–1052. 2005. View Article : Google Scholar : PubMed/NCBI
28	Chadjichristos CE, Matter CM, Roth I, Sutter E, Pelli G, Lüscher TF, Chanson M and Kwak BR: Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation. 113:2835–2843. 2006. View Article : Google Scholar : PubMed/NCBI
29	Chadjichristos CE, Morel S, Derouette JP, Sutter E, Roth I, Brisset AC, Bochaton-Piallat ML and Kwak BR: Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res. 102:653–660. 2008. View Article : Google Scholar : PubMed/NCBI
30	Song M, Yu X, Cui X, Zhu G, Zhao G, Chen J and Huang L: Blockade of connexin 43 hemichannels reduces neointima formation after vascular injury by inhibiting proliferation and phenotypic modulation of smooth muscle cells. Exp Biol Med (Maywood). 234:1192–1200. 2009. View Article : Google Scholar
31	Shi Y, Hou X, Zhang X, Wang Y, Chen Y and Zou J: Inhibition of oxidized-phospholipid-induced vascular smooth muscle cell proliferation by resveratrol is associated with reducing Cx43 phosphorylation. J Agric Food Chem. 61:10534–10541. 2013. View Article : Google Scholar : PubMed/NCBI
32	Johnstone SR, Ross J, Rizzo MJ, Straub AC, Lampe PD, Leitinger N and Isakson BE: Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation. Am J Pathol. 175:916–924. 2009. View Article : Google Scholar : PubMed/NCBI
33	Johnstone SR, Kroncke BM, Straub AC, Best AK, Dunn CA, Mitchell LA, Peskova Y, Nakamoto RK, Koval M, Lo CW, et al: MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation. Circ Res. 111:201–211. 2012. View Article : Google Scholar : PubMed/NCBI